RxDoctor Payments Data

Dinh Vu, MD

Family Medicine · Marietta, OHNPI 1467685198

Payments from drug & device makers

$432in general payments, 2019–2025

Across 20 payments — averaging $21.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$113
  • Amgen$69
  • GSK$47
  • Novo Nordisk$33
  • Pfizer$29
  • Exact Sciences$29
  • plus $111 from 6 others

What the payments were for

  • Food & beverage$432100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Johnson & Johnson(2 entities)2$113
Amgen4$69
GSK3$47
Novo Nordisk2$33
Pfizer2$29
Exact Sciences1$29
Abbott1$23
Merck1$20
Vertex1$19
Lilly USA, LLC1$17
Lundbeck LLC1$17
AstraZeneca1$15

How this compares

$432 in reported general payments places this provider in the 50th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$111,895
Medicare patients
475
Services billed
1,541

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol75$81,312
JanuviaSitagliptin Phosphate39$54,215
EliquisApixaban34$36,528
JardianceEmpagliflozin17$29,058
OzempicSemaglutide21$27,254
TradjentaLinagliptin13$18,739
Rosuvastatin Calcium406$6,746
Atorvastatin Calcium394$5,016
Levothyroxine Sodium314$4,053
Amlodipine Besylate523$3,527
Lantus SolostarInsulin Glargine,hum.Rec.Anlog17$3,180
Tamsulosin Hcl197$2,959
Losartan Potassium266$2,958
Metoprolol Succinate179$2,736
Verapamil SrVerapamil Hcl12$2,586

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga$15$81,31275 claims
MerckJanuvia$20$54,21539 claims
PfizerEliquis$29$36,52834 claims
Novo NordiskOzempic$33$27,25421 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Marietta

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →